J.J. Lafitte

Expression of IFN-γ–inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases

Deborah Miotto, Pota Christodoulopoulos, Ron Olivenstein et al. · Journal of Allergy and Clinical Immunology · 2001 · 150 citations · Full text

Veterinary Medicine, Immunology, Pathobiology +16

The sialylation of bronchial mucins secreted by patients suffering from cystic fibrosis or from chronic bronchitis is related to the severity of airway infection

M Davril, P. Humbert, C. Galabert et al. · Glycobiology · 1999 · 121 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +11

Valproate–doxorubicin: promising therapy for progressing mesothelioma. A phase II study

Arnaud Scherpereel, Thierry Berghmans, J.J. Lafitte et al. · European Respiratory Journal · 2010 · 94 citations · Full text

Medicine, Oncology, Pharmacology +10

Use of lectins for detection of glycoconjugates in the glandular cells of the human bronchial mucosa.

M Mazzuca, Michel Lhermitte, J.J. Lafitte et al. · Journal of Histochemistry & Cytochemistry · 1982 · 90 citations

Life Sciences, Biochemistry, Molecular Biology +17

A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics

Sculier Jp, M Paesmans, J. Lecomte et al. · British Journal of Cancer · 2001 · 66 citations · Full text

Medicine, Oncology, Pharmacology +12